|
1）Markar SR, Wiggins T, Ni M, et al. Assessment of the quality of surgery within randomized controlled trials for the treatment of gastro-oesophageal cancer: a systematic review. Lancet Oncol. 2015; 16: e23-31
|
|
|
|
2）Ma GW, Situ DR, Ma QL, et al. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol. 2014; 20: 18022-30
|
|
|
|
|
|
3）van der Schaaf M, Johar A, Wijnhoven B, et al. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst. 2015 Mar 5; 107(5). pii: djv043. doi: 10.1093/jnci/djv043
|
|
|
|
|
|
4）Noordman BJ, van Lanschot JJ. Gastrointestinal cancer: Effect of lymphadenectomy on survival in oesophageal cancer. Nat Rev Clin Oncol. 2015; 12: 315-6
|
|
|
|
|
|
5）Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomized controlled trial. Lancet Oncol. 2006; 7: 644-51
|
|
|
|
|
|
6）Kurokawa Y, Sasako M, Sano T, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg. 2015; 102: 341-8
|
|
|
|
|
|
7）Kutup A, Nentwich MF, Bollschweiler E, et al. What Should Be the Gold Standard for the Surgical Component in the Treatment of Locally Advanced Esophageal Cancer: Transthoracic Versus Transhiatal Esophagectomy. Ann Surg. 2014; 206: 1016-22
|
|
|
|
|
|
8）Kobayashi N, Kohno T, Haruta S, et al. Pulmonary Metastasectomy Secondary to Esophageal Carcinoma: Long-Term Survival and Prognostic Factors. Ann Surg Oncol. 2014; 21: S365-9
|
|
|
|
|
|
9）Palazzo F, Rosato EL, Chaudhary A, et al. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. J Am Coll Surg. 2015; 220: 672-9
|
|
|
|
|
|
10）Luketich JD, Pennathur A, Franchetti Y, et al. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg. 2015; 261: 702-7
|
|
|
|
|
|
11）Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial. World J Surg. 2015; 39: 1986-93
|
|
|
|
|
|
12）Li J, Shen Y, Tan L, et al. Is minimally invasive esophagectomy beneficial to elderly patients with esophageal cancer? Surg Endosc. 2015; 29: 925-30
|
|
|
|
|
|
13）Zhou C, Zhang L, Wang H, et al. Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis. PLoS One. 2015; 10: e0132889. doi: 10.1371/journal.pone.0132889. eCollection 2015
|
|
|
|
|
|
14）Koyanagi K, Ozawa S, Tachimori Y. Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review. Surg Today. 2015 Apr 10. [Epub ahead of print]
|
|
|
|
|
|
15）van der Sluis PC, Ruurda JP, Verhage RJ, et al. Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer. Ann Surg Oncol. 2015 May 29. [Epub ahead of print]
|
|
|
|
|
|
16）Puntambekar S, Kenawadekar R, Kumar S, et al. Robotic transthoracic esophagectomy. BMC Surg. 2015 Apr 23; 15: 47. doi: 10.1186/s12893-015-0024-2
|
|
|
|
|
|
17）Hölscher AH, Bollschweiler E, Bogoevski D, et al. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014; 50: 2950-7
|
|
|
|
|
|
18）Gronnier C, Tréchot B, Duhamel A, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg. 2014; 260: 764-70
|
|
|
|
|
|
19）Robb WB, Dahan L, Mornex F, et al. Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized Controlled Trial. Ann Surg. 2015; 261: 902-8
|
|
|
|
|
|
20）Shapiro J, van Hagen P, Lingsma HF, et al. Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Ann Surg. 2014; 260: 807-13
|
|
|
|
|
|
21）Watanabe M, Mine S, Nishida K, et al. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery? Ann Surg Oncol. 2015 Apr 11. [Epub ahead of print]
|
|
|
|
|